Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Angelo Bellinvia"'
Autor:
Federico Emanuele Pozzi, Luisa Calì, Fabrizia D'Antonio, Arianna Ida Altomare, Micaela Sepe Monti, Massimiliano Panigutti, Adolfo Di Crosta, Rocco Palumbo, Laura Bonanni, Valentina Carlucci, Cinzia Bussè, Annachiara Cagning, Daniele Urso, Davide Vilella, Giancarlo Logroscino, Margherita Alberoni, Angelo Bellinvia, Elisabetta Farina, Francesca de Rino, Armando Gavazzi, Marta Zuffi, Giuseppe Bruno, Valentina Bessi, Matteo Cotta Ramusino, Giulia Perini, Alfredo Costa, Carlo Ferrarese, Ildebrando Appollonio, Lucio Tremolizzo
Publikováno v:
Frontiers in Dementia, Vol 2 (2023)
Behavioral and Psychological Symptoms of Dementia (BPSD) are a heterogeneous set of psychological and behavioral abnormalities seen in persons with dementia (PwD), significantly impacting their quality of life and that of their caregivers. Current as
Externí odkaz:
https://doaj.org/article/f4e0b01f831b49ee81437c1a17a3d9d8
Autor:
Emilio Portaccio, Angelo Bellinvia, Elio Prestipino, Benedetta Nacmias, Silvia Bagnoli, Lorenzo Razzolini, Luisa Pastò, Claudia Niccolai, Benedetta Goretti, Mattia Fonderico, Giovanni Bosco Zimatore, Nunzia Alessandra Losignore, Sandro Sorbi, Maria Pia Amato
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Introduction: Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family, involved in neuronal survival and synaptic plasticity. The BDNF Val66Met polymorphism is known to reduce BDNF expression and secretion; its role in multipl
Externí odkaz:
https://doaj.org/article/c9f319fad9b4455a8f8f304c9b41c9fc
Autor:
Marco Allinovi, Angelo Bellinvia, Francesco Pesce, Sabrina Milan Manani, Lorenzo Razzolini, Brigida Brezzi, Paolo Protopapa, Vittorio Mantero, Leonardo Caroti, Calogero Lino Cirami, Maria Pia Amato, Lucia Del Vecchio
Publikováno v:
Brain Sciences, Vol 11, Iss 10, p 1341 (2021)
(1) Background: Complement system activation has been proposed as one of the different factors that contribute to Multiple Sclerosis (MS) pathogenesis. In this study, we aimed to describe the potential effects of eculizumab, an anticomplement therapy
Externí odkaz:
https://doaj.org/article/8af3bbe23c4c4af18840a736b6132817
Autor:
Mattia Fonderico, Emilio Portaccio, Lorenzo Razzolini, Luisa Pastò, Angelo Bellinvia, Ilaria Addazio, Matteo Betti, Maria Grazia Aprea, Clara Ballerini, Tiziana Biagioli, Maria Pia Amato
Publikováno v:
Brain Sciences, Vol 11, Iss 11, p 1444 (2021)
The presence of intrathecal IgM synthesis (ITMS) has been associated with an aggressive multiple sclerosis (MS) clinical course. In the present systematic review, we aimed at assessing the prevalence of ITMS among different MS phenotypes. Moreover, w
Externí odkaz:
https://doaj.org/article/2c725d62e9db4816ba5f02c4bc7e90ac
Publikováno v:
Brain Sciences, Vol 11, Iss 4, p 442 (2021)
Multiple sclerosis (MS) is one of the leading causes of disability in young adults. The onset of MS during developmental age makes pediatric patients particularly susceptible to cognitive impairment, resulting from both disease-related damage and fai
Externí odkaz:
https://doaj.org/article/89c57b7a3fa8477a8e52aae225273c70
Autor:
Maria Pia Amato, Elio Prestipino, Angelo Bellinvia, Claudia Niccolai, Lorenzo Razzolini, Luisa Pastò, Roberto Fratangelo, Laura Tudisco, Mattia Fonderico, Paolo Luca Mattiolo, Benedetta Goretti, Giovanni Bosco Zimatore, Nunzia Alessandra Losignore, Emilio Portaccio, Francesco Lolli
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0225494 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0222929.].
Externí odkaz:
https://doaj.org/article/34f5f750189f42348cddd97f5cb3717a
Autor:
Maria Pia Amato, Elio Prestipino, Angelo Bellinvia, Claudia Niccolai, Lorenzo Razzolini, Luisa Pastò, Roberto Fratangelo, Laura Tudisco, Mattia Fonderico, Paolo Luca Mattiolo, Benedetta Goretti, Giovanni Bosco Zimatore, Nunzia Alessandra Losignore, Emilio Portaccio, Francesco Lolli
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0222929 (2019)
BACKGROUND:Many potentially modifiable risk factors for MS are investigated. It is not known, however, if these factors also apply to MS-related cognitive impairment (CI), a frequent consequence of MS. OBJECTIVE:The aim of our study was to assess ris
Externí odkaz:
https://doaj.org/article/c9440ab063cd4cdb850f819becf016ca
Publikováno v:
Expert Opinion on Pharmacotherapy. 24:435-451
Cognitive impairment (CI) is a core feature of Multiple Sclerosis (MS), being detectable in up to 65% of subjects. Treatment of CI can be considered of paramount importance. However, no standardized strategies are available to date to define the best
Autor:
Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, Maria Pia Amato, Tobias Derfuss, Franziska Di Pauli, Ellen Iacobaeus, Marcin Mycko, Hesham Abboud, Anat Achiron, Angelo Bellinvia, Alexey Boyko, Jean-Laurent Casanova, David Clifford, Ruth Dobson, Mauricio F Farez, Massimo Filippi, Kathryn C Fitzgerald, Mattia Fonderico, Riadh Gouider, Yael Hacohen, Kerstin Hellwig, Bernhard Hemmer, Ludwig Kappos, Filipa Ladeira, Christine Lebrun-Frénay, Céline Louapre, Melinda Magyari, Matthias Mehling, Celia Oreja-Guevara, Lekha Pandit, Caroline Papeix, Fredrik Piehl, Emilio Portaccio, Isabel Ruiz-Camps, Krzysztof Selmaj, Steve Simpson-Yap, Aksel Siva, Per Soelberg Sorensen, Maria Pia Sormani, Maria Trojano, Adi Vaknin-Dembinsky, Sandra Vukusic, Brian Weinshenker, Heinz Wiendl, Alexander Winkelmann, María Isabel Zuluaga Rodas, Mar Tintoré, Bruno Stankoff
Publikováno v:
Multiple Sclerosis Journal. 28:1424-1456
Over the recent years, the treatment of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) has evolved very rapidly and a large number of disease-modifying treatments (DMTs) are now available. However, most DMTs are associated
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study
Autor:
Emilio Portaccio, Angelo Bellinvia, Mattia Fonderico, Luisa Pastò, Lorenzo Razzolini, Rocco Totaro, Daniele Spitaleri, Alessandra Lugaresi, Eleonora Cocco, Marco Onofrj, Franco Di Palma, Francesco Patti, Davide Maimone, Paola Valentino, Paolo Confalonieri, Alessandra Protti, Patrizia Sola, Giacomo Lus, Giorgia Teresa Maniscalco, Vincenzo Brescia Morra, Giuseppe Salemi, Franco Granella, Ilaria Pesci, Roberto Bergamaschi, Umberto Aguglia, Marika Vianello, Marta Simone, Vito Lepore, Pietro Iaffaldano, Massimo Filippi, Maria Trojano, Maria Pia Amato
Portaccio et al. report that in early relapsing-onset multiple sclerosis, progression independent of relapse activity is an important contributor to disability accumulation. Insidious progression occurs even in the earliest disease phases, suggesting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47a646bfa7ff601ba10ba1c809c7722e
https://hdl.handle.net/10447/584677
https://hdl.handle.net/10447/584677